Connection

Wu Zhong to Betacoronavirus

Back to Details
This is a "connection" page, showing publications Wu Zhong has written about Betacoronavirus.
Wu Zhong
Connection Strength
0.116
Betacoronavirus
  1. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2020 10 15; 5(1):240.
    View in: PubMed
    Score: 0.039
  2. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. ACS Infect Dis. 2020 09 11; 6(9):2524-2531.
    View in: PubMed
    Score: 0.038
  3. Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2. Future Med Chem. 2020 09; 12(17):1565-1578.
    View in: PubMed
    Score: 0.009
  4. Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination. Emerg Microbes Infect. 2020; 9(1):545-547.
    View in: PubMed
    Score: 0.009
  5. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
    View in: PubMed
    Score: 0.009
  6. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020 03; 63(3):457-460.
    View in: PubMed
    Score: 0.009
  7. Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series. Crit Care. 2020 09 25; 24(1):578.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.